Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News STRATA Skin Sciences Inc SSKN

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC... see more

Current News (NDAQ:SSKN)

STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 - Reports Early Adoption Momentum in Mexico

GlobeNewswire December 9, 2025

STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire November 13, 2025

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion

GlobeNewswire November 6, 2025

STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update

GlobeNewswire November 5, 2025

STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements

GlobeNewswire October 28, 2025

STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek

GlobeNewswire October 20, 2025

Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides

GlobeNewswire October 14, 2025

Marking Eczema Awareness Month - Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis

GlobeNewswire October 3, 2025

STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis

GlobeNewswire September 30, 2025

Opinion & Analysis (NDAQ:SSKN)

No current opinion is available.

Bullboard Posts (NDAQ:SSKN)

Using technical analysis for this stock.

It is signalling a big upswing for shareholders today,so good luck to all of you guys
coolfooldumbguy - October 14, 2025

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - September 23, 2025

Using technical analysis for this stock.

It is starting to go into an uptrend for shareholders today,so good luck to all of you guys
coolfooldumbguy - September 2, 2025

SSKN: Navigating a Turnaround with Promising Potential

http://beyondspx.com/2024/08/02/sskn-navigating-a-turnaround-with-promising-potential/
MikeTester - August 3, 2024

Back to $ 1.14.....

Good to start again or hands off ?
bogi - June 30, 2015

RE:RE:technicals

This woman CEO is ruining this company single handedly!  What a joke!!Great idea and product, terrrible management.  Another...
Driftwood17 - June 23, 2015

Podcasts